MarketGrader Indexes – 2023 Performance Review
MarketGrader’s stock selection methodology shone in 2023, as 75% of our indexes outperformed their benchmarks in what turned out to be a strong year for most equity markets around the world.
MarketGrader’s stock selection methodology shone in 2023, as 75% of our indexes outperformed their benchmarks in what turned out to be a strong year for most equity markets around the world.
MarketGrader’s stock selection methodology shone in 2023, as 75% of our indexes outperformed their benchmarks in what turned out to be a strong year for most equity markets around the world.
Given the lackluster performance of Chinese equities in 2021, Australian investors may be questioning the value of having a dedicated exposure to the asset class
We’re very excited to announce our latest collaboration with VanEck—the first one with VanEck Europe—which expands the list of China-focused ETFs tracking a MarketGrader Index
China’s government has been talking about deleveraging its economy to reduce systemic financial risks since at least 2015. The policies it has implemented to curb
Health Care stocks have quietly posted some of the best returns among all developed market sectors this year, matching the broad benchmark returns in what
India’s economy, the sixth largest in the world, is expected to grow 9.6% this year after a decline of 7.3% in 2020, according to economists’
The CSI MarketGrader China New Economy Index (CNE) managed to avoid the worst of the fallout from rout in the education and technology stocks that
The current joke in the Chinese gaming industry says, “there are only three gaming companies in China: Tencent Games, NetEase Games, and ‘Others.’” The cruel
(Commentary on Chinese stocks, and the indexes that track them, is often done in the abstract with little time spent discussing the companies that make
While Chinese equities usually get most of the headlines among emerging markets, India has been quietly making the case for being the best performing large
MarketGrader’s stock selection methodology shone in 2023, as 75% of our indexes outperformed their benchmarks in what turned out to be a strong year for most equity markets around the world.
Investors in Chinese equities should move past macroeconomic concerns and focus instead on the country’s technological transformation.
Market Imbalance Sets Up Fundamental Investing for Big Comeback Here’s our list of some
In 2022 investors rediscovered the importance of capital allocation when money is no longer
Investors Continue to Underestimate the Impact Higher Interest Rates Are Having Across the Economy. Beware Expensive Large Cap Stocks.
Part 1 of 3. The Tactical Case for China With 2022 coming to an
The Barron’s 400 index approach is focused on consistency rather than market timing. To
MarketGrader’s ratings, which are designed to help investors identify the world’s best compounders of
Our Take on the 20th Party Congress of the Chinese Communist Party Clarity is
The Barron’s 400 Index (B400) started the week with a newly reconstituted roster of